AUS
NZ
UK
CA
USA
IND
Healt
All Ordinaries Healthcare Update as 4DMedical Gains Entry
April 20, 2026 11:35 AM AEST| By Sam4DMedical’s inclusion in the ASX benchmark highlights healthcare sector participation, reflecting evolving index composition and the role of medical technology within the Australian market.
ASX 300 Healthcare Play: Why Mesoblast Is Back in Focus
April 20, 2026 10:40 AM AEST| By SamMesoblast gains renewed attention after clinical progress and early commercial traction, strengthening its position within ASX 300 healthcare stocks and highlighting its evolving long-term growth narrative.
Mesoblast (ASX:MSB; NASDAQ:MESO) Accelerates Growth Strategy with CAR Tech and Commercial Momentum
April 20, 2026 04:05 AM AEST| By Team Kalkine MediaHighlights,Mesoblast advances its platform with the acquisition of CAR technology for MSC therapies.,The company has reported Ryoncil® revenue approaching US$100 million since launch.,CAR-MSC approach aims to enhance tissue targeting and treatment po...
Mesoblast (ASX:MSB) Drives ASX 200 Healthcare Buzz?
April 20, 2026 03:11 AM AEST| By SamMesoblast (ASX:MSB) gains attention following regulatory progress, highlighting biotechnology sector developments and healthcare participation across ASX indices.
Healthcare Sector Movement Drives ASX All Ords Attention
April 17, 2026 11:58 AM AEST| By SamCareteq reflects market valuation movement within the digital health sector, highlighting shareholder positioning and participation across ASX All Ords.
Is Orthocell (ASX:OCC) Expanding Its Role in ASX All Ordinaries Biotech Sector?
April 17, 2026 11:39 AM AEST| By SamOrthocell completes a Remplir procedure in a US military hospital network, highlighting clinical deployment and biotechnology sector participation within ASX All Ordinaries.
ASX 200 Healthcare Sector Sees Rising Market Focus
April 17, 2026 11:27 AM AEST| By SamASX healthcare sector activity highlights market participation and corporate developments, reflecting integration of biotechnology and pharmaceutical companies across major indices.
ASX 300 Insight: Why Oneview Is Expanding CDIs?
April 17, 2026 10:47 AM AEST| By SamOneview Healthcare has expanded its CDI base through an ASX quotation, improving liquidity and accessibility while continuing to support its growth in digital healthcare solutions and patient engagement platforms.
ASX 300 Update: What’s Driving Firebrick Pharma’s Share Move?
April 17, 2026 10:39 AM AEST| By SamFirebrick Pharma has expanded its share base through an ASX quotation, enhancing liquidity and funding flexibility while shifting focus toward execution and development across its biotechnology pipeline.
Can BlinkLab’s Fresh Capital Drive Its Next Big Break?
April 16, 2026 05:06 PM AEST| By SamBlinkLab advances autism and ADHD diagnostics through funding, clinical trials, and real-world deployment, strengthening its digital healthcare platform and regulatory progress.
Is (ASX:BB1) Entering a New Phase in Digital Diagnostics?
April 16, 2026 03:33 PM AEST| By SamBlinkLab advances digital diagnostics with new funding, supporting clinical trials, regulatory expansion, and global deployment of its smartphone-based neurodevelopmental screening platforms.
ASX 100 Healthcare Giant: Why COH Shares Are Under Spotlight
April 16, 2026 10:04 AM AEST| By SamCochlear shares are under focus after a pullback, with healthcare resilience, global demand, and valuation dynamics shaping its outlook as a key ASX 100 medical technology company.
Is Lumos Diagnostics (ASX:LDX) Shaping ASX All Ordinaries Healthcare Landscape?
April 15, 2026 06:04 PM AEST| By SamLumos Diagnostics outlines reporting plans and investor engagement while advancing its share purchase plan, reflecting continued activity within the healthcare diagnostics sector.
All Ordinaries Spotlight: Orthocell Expands Remplir Access
April 15, 2026 01:06 PM AEST| By SamOrthocell expanded access to US military and veterans hospitals, advancing Remplir distribution and strengthening its presence in the global healthcare sector.
SHL Under Pressure: Hidden Opportunity in ASX 100 Healthcare?
April 15, 2026 10:41 AM AEST| By SamSonic Healthcare’s valuation and global presence highlight a defensive yet growth-oriented profile, with healthcare demand stability and international expansion shaping its outlook despite recent share price weakness.
Telix Bond Boost: Is ASX 100 Healthcare Story Resetting?
April 15, 2026 10:27 AM AEST| By SamTelix upsized its bond offering, strengthening financial flexibility and refining its capital structure, with future performance linked to clinical execution and global expansion in the healthcare sector.
Ryman Healthcare Sales Rise Despite Network Changes
April 15, 2026 10:13 AM AEST| By SamRyman Healthcare reported steady Q4 sales growth supported by strong occupancy and serviced apartment demand, maintaining resilience despite village closures and broader economic uncertainty affecting global markets.
Can PainChek’s US Deal Redefine Aged Care Tech?
April 14, 2026 06:33 PM AEST| By SamPainChek strengthens global presence through a US partnership, advancing AI-based pain assessment adoption across aged care facilities while scaling its reach in healthcare technology markets.
Is Entropy Neurodynamics Driving All Ords with Trial Gains?
April 14, 2026 05:07 PM AEST| By SamEntropy Neurodynamics advances clinical research with TRP program development, controlled infusion methods, and strengthened funding within the ASX healthcare sector.
Could This ASX Biotech Be Gearing Up for a Key Breakthrough?
April 14, 2026 04:53 PM AEST| By SamPercheron Therapeutics advances its oncology program with fresh funding, supporting clinical progress and upcoming research milestones in the evolving biotech landscape.
Advertise your brand on Kalkine Media